Long Non-Coding RNA FLG-AS1 Inhibits Cervical Cancer Progression through Negatively Modulating miR-147b
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Filaggrin antisense RNA 1 (FLG-AS1) is downregulated in cervical cancer, inhibiting cancer cell progression by regulating miR-147b. Low FLG-AS1 expression indicates a poor prognosis for cervical cancer patients.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Cervical cancer remains a significant global health challenge.
- Identifying novel biomarkers and therapeutic targets is crucial for improving patient outcomes.
Purpose Of The Study
- To investigate the prognostic role of FLG-AS1 in cervical cancer.
- To elucidate the interaction mechanism between FLG-AS1 and miR-147b.
- To explore FLG-AS1 as a potential therapeutic target for cervical cancer.
Main Methods
- Analysis of FLG-AS1 expression in 125 cervical cancer tissue samples using polymerase chain reaction.
- Assessment of FLG-AS1's effect on cell proliferation and metastasis via CCK-8 and Transwell assays.
- Investigation of the FLG-AS1/miR-147b interaction using dual luciferase reporter gene assay and statistical analysis.
Main Results
- FLG-AS1 expression was significantly downregulated in cervical cancer tissues and cells.
- FLG-AS1 demonstrated an inhibitory effect on cervical cancer cell activities by negatively regulating miR-147b.
- Low FLG-AS1 expression correlated with a poor prognosis in cervical cancer patients.
Conclusions
- FLG-AS1 serves as a potential prognostic biomarker for cervical cancer.
- FLG-AS1 influences cervical cancer progression through its negative regulation of miR-147b.
- Targeting the FLG-AS1/miR-147b axis may offer a novel therapeutic strategy for cervical cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...